Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control
This case study underscored the potential of BNCT as a promising treatment modality for MCS, particularly for tumors that are resistant to conventional radiation therapy. Further research is warranted to refine treatment protocols and explore the broader applicability of BNCT in managing MCS and other challenging malignancies.
Authors
- Xiaohua Zhu (ORCID: https://orcid.org/0000-0002-1048-3590)
- Diyun Shu
- Qiuping Gong
- Ping Zhou (ORCID: https://orcid.org/0000-0001-9680-1651)
- Youqun Lai (ORCID: https://orcid.org/0000-0001-5417-8312)
- Mu Mei
- Yi-Chiao Teng (ORCID: https://orcid.org/0000-0001-9256-0889)
- Xiaodong Lin (ORCID: https://orcid.org/0000-0001-8916-6645)
- Cheng Huang (ORCID: https://orcid.org/0000-0003-1722-6834)
- Wenyu Xu
- Jinsheng Hong (ORCID: https://orcid.org/0000-0003-0954-5923)
- Ye Cao
- Xingyan Liu (ORCID: https://orcid.org/0000-0001-5117-0606)
- Jianji Pan
- Yuan‐Hao Liu (ORCID: https://orcid.org/0009-0006-4013-9973)
- Shuang Fu
- Mingang Ying
- Qiuli Lai
Institutions
- First Affiliated Hospital of Xiamen University (CN)
- Neuboron (China) (CN)
- 174th hospital of the People's Liberation Army (CN)
- Xiamen Chang Gung Hospital (CN)
- BioNTech (United States) (US)
- Tongji Hospital (CN)
- Nanjing University of Aeronautics and Astronautics (CN)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.adro.2025.101897
- Citations
- 2
- Primary Topic
- Boron Compounds in Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- National Natural Science Foundation of China